Home/Filings/4/0001104659-23-000335
4//SEC Filing

Richardson Linda M 4

Accession 0001104659-23-000335

CIK 0001270073other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:02 PM ET

Size

4.9 KB

Accession

0001104659-23-000335

Insider Transaction Report

Form 4
Period: 2022-12-31
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-12-31$12.37/sh1,600$19,79231,477 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001595064

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:02 PM ET
Size
4.9 KB